Cargando…
Predictive value of baseline metabolic tumor burden on (18)F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer
OBJECTIVES: Brain metastases (BMs) are a major cause leading to the failure of treatment management for non-small-cell lung cancer (NSCLC) patients. The purpose of this study was to evaluate the predictive value of baseline metabolic tumor burden on (18)F-FDG PET/CT measured with metabolic tumor vol...
Autores principales: | Shang, Jingjie, You, Huimin, Dong, Chenchen, Li, Yingxin, Cheng, Yong, Tang, Yongjin, Guo, Bin, Gong, Jian, Ling, Xueying, Xu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643834/ https://www.ncbi.nlm.nih.gov/pubmed/36387169 http://dx.doi.org/10.3389/fonc.2022.1029684 |
Ejemplares similares
-
Precision of quantitative parameters of (18)F-FDG PET/CT in a rabbit VX2 tumor model
por: Guo, Bin, et al.
Publicado: (2023) -
(18)F-FDG PET/CT and PET/MRI fusion imaging for neuroendocrine carcinoma of the tongue: A case report
por: Zeng, Chunyuan, et al.
Publicado: (2022) -
The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023) -
(18)F FDG-PET/CT of malignant thymoma with pleural and diaphragmatic metastases
por: Gajendra, Smeeta, et al.
Publicado: (2016) -
Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)